H-Guard: Improving Physical and Mental Health

Published: Jan. 16, 2024, 9 a.m.

For the 850 million people around the world suffering from chronic kidney disease, the grind of dialysis treatment can wear them down in more ways than one.\xa0 \xa0

\xa0

Dr. Andy Herbert, co-founder of Invizius, is out to change that. This five-year-old company started from humble beginnings and is currently developing H-Guard\xae Priming Solution, which increases the effectiveness of dialysis while negating, or eliminating, its potentially dangerous side effects. It will be used in an upcoming first-in-human clinical trial and has the potential to improve patients\u2019 quality of life \u2013 both physically and mentally. \xa0

\xa0

Join Dr. Herbert as we discuss the origins of Invizius, how H-Guard works, why dialysis can take a toll on mental health, and how working with a strategic partner has helped Invizius progress this treatment.

Show Notes\u202f\xa0

\xa0
Invizius\xa0

Charles River's Nonclinical Support Helps Invizius Secure MHRA Approval for First-in-Human Trial of H-Guard\xae Hemodialysis Solution\xa0

Renal Disorders | Charles River\xa0

Preclinical CRO Services for Safety Assessment\xa0

Inflammation | Charles River